Gilde Healthcare picks up Sanquin Reagents

Sanquin Reagents is the first investment of Gilde Healthcare's €517 million Private Equity Fund IV.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this